Interaction of Antagonists with Calmodulin: Insights from Molecular Dynamics Simulations

Journal of Medicinal Chemistry
2008.0

Abstract

We report results of 12 ns, all-atom molecular dynamics simulation (MDS) and Poisson-Boltzmann free energy calculations (PBFE) on calmodulin (CaM) bound to two molecules of trifluoperazine (TFP) and of N-(3,3, diphenylpropyl)- N'-[1- R-(3,4-bis-butoxyphenyl)-ethyl]-propylenediamine (DPD). X-ray data show very similar structures for the two complexes, yet the antagonists significantly differ with respect to their CaM binding affinities, the neutral DPD is much more potent. The goal of the study was to unravel the reason why TFP is less potent although its positive charge should facilitate binding. The electrostatic energy terms in CHARMM and binding free energy terms of the PBFE approach showed TFP a better antagonist, while inspection of hydrophobic contacts supports DPD binding. Detailed inspection of the amino acid contributions of PBFE calculations unravel that steric reasons oppose the favorable binding of TFP. Structural conditions are given for a successful drug design strategy, which may benefit also from charge-charge interactions.

Knowledge Graph

Similar Paper

Interaction of Antagonists with Calmodulin: Insights from Molecular Dynamics Simulations
Journal of Medicinal Chemistry 2008.0
A molecular-modeling study of the interactions between the antiestrogen drug tamoxifen and several derivatives, and the calcium-binding protein calmodulin
Journal of Medicinal Chemistry 1992.0
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein–Protein Interaction Inhibitors Targeting the EphA2 Receptor
Journal of Medicinal Chemistry 2017.0
Synthesis, biological evaluation, and docking studies of gigantol analogs as calmodulin inhibitors
European Journal of Medicinal Chemistry 2011.0
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches
Bioorganic & Medicinal Chemistry 2011.0
Fluorescence, circular dichroism, NMR, and docking studies of the interaction of the alkaloid malbrancheamide with calmodulin
Journal of Enzyme Inhibition and Medicinal Chemistry 2011.0
Rationally Designed Analogs of Tamoxifen with Improved Calmodulin Antagonism
Journal of Medicinal Chemistry 1995.0
Development of the Fluorescent BiosensorhCalmodulin (hCaM)L39C-monobromobimane(mBBr)/V91C-mBBr, a Novel Tool for Discovering New Calmodulin Inhibitors and Detecting Calcium
Journal of Medicinal Chemistry 2011.0
Computational analysis of the binding affinities of the natural-product cyclopentapeptides argifin and argadin to chitinase B from Serratia marcescens
Bioorganic & Medicinal Chemistry 2008.0
A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties
Journal of Medicinal Chemistry 1990.0